PET imaging in ischemic cerebrovascular disease: current status and future directions

Neuroscience Bulletin

Volumn , Issue , 2014, Pages 713-732

  Heiss, Wolf Dieter ^a  

^a MAX PLANCK INSTITUTE FOR NEUROLOGICAL RESEARCH   (Germany)

Author keywords

brain ischemia; brain metabolism; dementia; PET; stroke

Indexed keywords

FLUMAZENIL;

BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; DIAGNOSTIC USE; HUMAN; METABOLISM; MICROGLIA; POSITRON EMISSION TOMOGRAPHY; SCINTISCANNING;

BRAIN ISCHEMIA; FLUMAZENIL; HUMANS; MICROGLIA; POSITRON-EMISSION TOMOGRAPHY; STROKE;

EID: 84930278749     PISSN: 16737067     EISSN: 19958218     Source Type: Journal    
DOI: 10.1007/s12264-014-1463-y     Document Type: Review

References (121)

1. World Health Organisation 2008. Burden of Disease Statistics. Geneva: WHO Press.
2. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006, 367: 1747–1757.
3. Johnston SC, Mendis S, Mathers CD. Global variation in stroke burden and mortality: estimates from monitoring, surveillance, and modelling. Lancet Neurol 2009, 8: 345–354.
4. Leary MC, Saver JL. Annual incidence of first silent stroke in the United States: a preliminary estimate. Cerebrovasc Dis 2003, 16: 280–285.
5. Pakkenberg B, Gundersen HJ. Neocortical neuron number in humans: effect of sex and age. J Comp Neurol 1997, 384: 312–320.
6. Clarke DD, Sokoloff L. Circulation and energy metabolism of the brain. In: Siegel GJ, Agranoff BW, Albers RW, et al. (Eds.). Basic Neurochemistry: Molecular, Cellular, and Medical Aspects, 6th ed. Philadelphia: Lippincott-Raven, 1999: 637–669.
7. Sokoloff L. Energetics of functional activation in neural tissues. Neurochem Res 1999, 24: 321–329.
8. Laughlin SB, Attwell D. The metabolic cost of neural information: from fly eye to mammalian cortex. In: Frackowiak RSI, Magistretti PI, Shulman RG, et al. (Eds.). Neuroenergetics: Relevance for Functional Brain Imaging. Strasbourg: HFSP Workshop XI, 2001: 54–64.
9. Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 1999, 22: 391–397.
10. Hossmann KA. Pathophysiological basis of translational stroke research. Folia Neuropathol 2009, 47: 213–227.
11. Astrup J, Siesjö BK, Symon L. Thresholds in cerebral ischemia — the ischemic penumbra. Stroke 1981, 12: 723–725.
12. Heiss WD, Rosner G. Functional recovery of cortical neurons as related to degree and duration of ischemia. Ann Neurol 1983, 14: 294–301.
13. Ackerman RH, Correia JA, Alpert NM, Baron JC, Gouliamos A, Grotta JC, et al. Positron imaging in ischemic stroke disease using compounds labeled with oxygen 15. Initial results of clinicophysiologic correlations. Arch Neurol 1981, 38: 537–543.
14. Baron JC, Bousser MG, Comar D, Soussaline F, Castaigne P. Noninvasive tomographic study of cerebral blood flow and oxygen metabolism in vivo. Potentials, limitations, and clinical applications in cerebral ischemic disorders. Eur Neurol 1981, 20: 273–284.
15. Lenzi GL, Frackowiak RSJ, Jones T. Cerebral oxygen metabolism and blood flow in human cerebral ischemic infarction. J Cereb Blood Flow Metab 1982, 2: 321–335.
16. Powers WJ, Grubb RL, Jr., Darriet D, Raichle ME. Cerebral blood flow and cerebral metabolic rate of oxygen requirements for cerebral function and viability in humans. J Cereb Blood Flow Metab 1985, 5: 600–608.
17. Heiss WD. Ischemic penumbra: evidence from functional imaging in man. J Cereb Blood Flow Metab 2000, 20: 1276–1293.
18. Powers WJ, Zazulia AR. PET in cerebrovascular disease. PET Clin 2010, 5: 83106.
19. Heiss WD. David sherman lecture 2012: the role of positron emission tomography for translational research in stroke. Stroke 2012, 43: 2520–2525.
20. Heiss WD, Huber M, Fink GR, Herholz K, Pietrzyk U, Wagner R, et al. Progressive derangement of periinfarct viable tissue in ischemic stroke. J Cereb Blood Flow Metab 1992, 12: 193–203.
21. Baron JC. Mapping the ischaemic penumbra with PET: implications for acute stroke treatment. Cerebrovasc Dis 1999, 9: 193–201.
22. Graf R, Löttgen J, Ohta K, Wagner R, Rosner G, Pietrzyk U, et al. Dynamics of postischemic perfusion following transient MCA occlusion in cats determined by sequential PET. J Cereb Blood Flow Metab 1997, 17,Suppl. 1: S323.
23. Guadagno JV, Jones PS, Aigbirhio FI, Wang D, Fryer TD, Day DJ, et al. Selective neuronal loss in rescued penumbra relates to initial hypoperfusion. Brain 2008, 131: 2666–2678.
24. Barber PA, Darby DG, Desmond PM, Yang Q, Gerraty RP, Jolley D, et al. Prediction of stroke outcome with echoplanar perfusion-weighted and diffusion-weighted MRI. Neurology 1998, 51: 418–426.
25. Kidwell CS, Alger JR, Saver JL. Beyond mismatch: evolving paradigms in imaging the ischemic penumbra with multimodal magnetic resonance imaging. Stroke 2003, 34: 2729–2735.
26. Heiss WD, Sobesky J, Smekal U, Kracht LW, Lehnhardt FG, Thiel A, et al. Probability of cortical infarction predicted by flumazenil binding and diffusion-weighted imaging signal intensity: a comparative positron emission tomography/magnetic resonance imaging study in early ischemic stroke. Stroke 2004, 35: 1892–1898.
27. Kane I, Carpenter T, Chappell F, Rivers C, Armitage P, Sandercock P, et al. Comparison of 10 different magnetic resonance perfusion imaging processing methods in acute ischemic stroke: effect on lesion size, proportion of patients with diffusion/perfusion mismatch, clinical scores, and radiologic outcomes. Stroke 2007, 38: 3158–3164.
28. Sobesky J, Weber OZ, Lehnhardt FG, Hesselmann V, Neveling M, Jacobs A, et al. Does the mismatch match the penumbra? Magnetic resonance imaging and positron emission tomography in early ischemic stroke. Stroke 2005, 36: 980–985.
29. Takasawa M, Jones PS, Guadagno JV, Christensen S, Fryer TD, Harding S, et al. How reliable is perfusion MR in acute stroke? Validation and determination of the penumbra threshold against quantitative PET. Stroke 2008, 39: 870–877.
30. Zaro-Weber O, Moeller-Hartmann W, Heiss WD, Sobesky J. The performance of MRI-based cerebral blood flow measurements in acute and subacute stroke compared with 15O-water positron emission tomography: identification of penumbral flow. Stroke 2009, 40: 2413–2421.
31. Olivot JM, Albers GW. Diffusion-perfusion MRI for triaging transient ischemic attack and acute cerebrovascular syndromes. Curr Opin Neurol 2011, 24: 44–49.
32. Hernandez DA, Bokkers RP, Mirasol RV, Luby M, Henning EC, Merino JG, et al. Pseudocontinuous arterial spin labeling quantifies relative cerebral blood flow in acute stroke. Stroke 2012, 43: 753–758.
33. Campbell BC, Christensen S, Levi CR, Desmond PM, Donnan GA, Davis SM, et al. Cerebral blood flow is the optimal CT perfusion parameter for assessing infarct core. Stroke 2011, 42: 3435–3440.
34. Mathias CJ, Welch MJ, Kilbourn MR, Jerabek PA, Patrick TB, Raichle ME, et al. Radiolabeled hypoxic cell sensitizers: Tracers for assessment of ischemia. Life Sci 1987, 41: 199–206.
35. Hoffman JM, Rasey JS, Spence AM, Shaw DW, Krohn KA. Binding of the hypoxia tracer [3H]misonidazole in cerebral ischemia. Stroke 1987, 18: 168–176.
36. Yeh SH, Liu RS, Hu HH, et al. Ischemic penumbra in acute stroke: demonstration by PET with fluorine-18 fluoromisonidazole. J Nucl Med 1994, 35: 205P.
37. Read SJ, Hirano T, Abbott DF, Sachinidis JI, Tochon-Danguy HJ, Chan JG, et al. Identifying hypoxic tissue after acute ischemic stroke using PET and 18F-fluoromisonidazole. Neurology 1998, 51: 1617–1621.
38. Markus R, Reutens DC, Kazui S, Read S, Wright P, Chambers BR, et al. Topography and temporal evolution of hypoxic viable tissue identified by 18F-fluoromisonidazole positron emission tomography in humans after ischemic stroke. Stroke 2003, 34: 2646–2652.
39. Read SJ, Hirano T, Abbott DF, Markus R, Sachinidis JI, Tochon-Danguy HJ, et al. The fate of hypoxic tissue on 18F-fluoromisonidazole PET after ischemic stroke. Ann Neurol 2000, 48: 228–235.
40. Markus R, Donnan G, Kazui S, Read S, Reutens D. Penumbral topography in human stroke: methodology and validation of the ‘Penumbragram’. Neuroimage 2004, 21: 1252–1259.
41. Saita K, Chen M, Spratt NJ, Porritt MJ, Liberatore GT, Read SJ, et al. Imaging the ischemic penumbra with 18F-fluoromisonidazole in a rat model of ischemic stroke. Stroke 2004, 35: 975–980.
42. Spratt NJ, Donnan GA, Howells DW. Characterisation of the timing of binding of the hypoxia tracer FMISO after stroke. Brain Res 2009, 1288: 135–142.
43. Takasawa M, Beech JS, Fryer TD, Jones PS, Ahmed T, Smith R, et al. Single-subject statistical mapping of acute brain hypoxia in the rat following middle cerebral artery occlusion: a microPET study. Exp Neurol 2011, 229: 251–258.
44. Alawneh JA, Moustafa RR, Marrapu ST, Jensen-Kondering U, Morris RS, Jones PS, et al. Diffusion and perfusion correlates of the F-MISO PET lesion in acute stroke: pilot study. Eur J Nucl Med Mol Imaging 2014, 41(4): 736–744.
45. Lees KR, Bluhmki E, von Kummer R, Brott TG, Toni D, Grotta JC, et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 2010, 375: 1695–1703.
46. Grotta JC, Alexandrov AV. tPA-associated reperfusion after acute stroke demonstrated by SPECT. Stroke 1998, 29: 429–432.
47. Heiss WD, Grond M, Thiel A, von Stockhausen HM, Rudolf J, Ghaemi M, et al. Tissue at risk of infarction rescued by early reperfusion: a positron emission tomography study in systemic recombinant tissue plasminogen activator thrombolysis of acute stroke. J Cereb Blood Flow Metab 1998, 18: 1298–1307.
48. 2O positron emission tomography predicts irreversible ischemic cortical damage in stroke patients receiving acute thrombolytic therapy. Stroke 2000, 31: 366–369.
49. Hossmann KA. Pathophysiology and therapy of experimental stroke. Cell Mol Neurobiol 2006, 26: 1057–1083.
50. Nakamura H, Strong AJ, Dohmen C, Sakowitz OW, Vollmar S, Sue M, et al. Spreading depolarizations cycle around and enlarge focal ischaemic brain lesions. Brain 2010, 133: 1994–2006.
51. Dohmen C, Sakowitz OW, Fabricius M, Bosche B, Reithmeier T, Ernestus RI, et al. Spreading depolarizations occur in human ischemic stroke with high incidence. Ann Neurol 2008, 63: 720–728.
52. Juttler E, Bosel J, Amiri H, Schiller P, Limprecht R, Hacke W, et al. DESTINY II: DEcompressive Surgery for the Treatment of malignant INfarction of the middle cerebral arterY II. Int J Stroke 2011, 6: 79–86.
53. Dohmen C, Bosche B, Graf R, Staub F, Kracht L, Sobesky J, et al. Prediction of malignant course in MCA infarction by PET and microdialysis. Stroke 2003, 34: 2152–2158.
54. Hanisch UK, Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci 2007, 10: 1387–1394.
55. Weinstein JR, Koerner IP, Moller T. Microglia in ischemic brain injury. Future Neurol 2010, 5: 227–246.
56. Thiel A, Heiss WD. Imaging of microglia activation in stroke. Stroke 2011, 42: 507–512.
57. Rojas S, Martin A, Arranz MJ, Pareto D, Purroy J, Verdaguer E, et al. Imaging brain inflammation with [(11)C]PK11195 by PET and induction of the peripheral-type benzodiazepine receptor after transient focal ischemia in rats. J Cereb Blood Flow Metab 2007, 27: 1975–1986.
58. Demerle-Pallardy C, Duverger D, Spinnewyn B, Pirotzky E, Braquet P. Peripheral type benzodiazepine binding sites following transient forebrain ischemia in the rat: effect of neuroprotective drugs. Brain Res 1991, 565: 312–320.
59. Schroeter M, Dennin MA, Walberer M, Backes H, Neumaier B, Fink GR, et al. Neuroinflammation extends brain tissue at risk to vital peri-infarct tissue: a double tracer [11C]PK11195- and [18F]FDG-PET study. J Cereb Blood Flow Metab 2009, 29: 1216–1225.
60. Hughes JL, Jones PS, Beech JS, Wang D, Menon DK, Aigbirhio FI, et al. A microPET study of the regional distribution of [11C]-PK11195 binding following temporary focal cerebral ischemia in the rat. Correlation with post mortem mapping of microglia activation. Neuroimage 2012, 59: 2007–2016.
61. Tsukada H, Ohba H, Nishiyama S, Kanazawa M, Kakiuchi T, Harada N. PET imaging of ischemia-induced impairment of mitochondrial complex I function in monkey brain. J Cereb Blood Flow Metab 2014, 34(4): 708–714
62. Gerhard A, Schwarz J, Myers R, Wise R, Banati RB. Evolution of microglial activation in patients after ischemic stroke: a [11C](R)-PK11195 PET study. Neuroimage 2005, 24: 591–595.
63. Radlinska BA, Ghinani SA, Lyon P, Jolly D, Soucy JP, Minuk J, et al. Multimodal microglia imaging of fiber tracts in acute subcortical stroke. Ann Neurol 2009, 66: 825–832.
64. Thiel A, Radlinska BA, Paquette C, Sidel M, Soucy JP, Schirrmacher R, et al. The temporal dynamics of poststroke neuroinflammation: a longitudinal diffusion tensor imaging-guided PET study with 11C-PK11195 in acute subcortical stroke. J Nucl Med 2010, 51: 1404–1412.
65. Thiel A, Heiss W-D. Imaging of microglia activation in stroke. Stroke 2011, 42: 507–512.
66. Gibbs JM, Wise RJ, Leenders KL, Jones T. Evaluation of cerebral perfusion reserve in patients with carotid-artery occlusion. Lancet 1984, 1: 310–314.
67. Powers WJ, Press GA, Grubb RL, Jr., Gado M, Raichle ME. The effect of hemodynamically significant carotid artery disease on the hemodynamic status of the cerebral circulation. Ann Intern Med 1987, 106: 27–35.
68. Sette G, Baron JC, Mazoyer B, Levasseur M, Pappata S, Crouzel C. Local brain haemodynamics and oxygen metabolism in cerebrovascular disease. Positron emission tomography. Brain 1989, 112(Pt 4): 931–951.
69. Grubb RL, Jr., Derdeyn CP, Fritsch SM, Carpenter DA, Yundt KD, Videen TO, et al. Importance of hemodynamic factors in the prognosis of symptomatic carotid occlusion. JAMA 1998, 280: 1055–1060.
70. Yamauchi H, Fukuyama H, Nagahama Y, Nabatame H, Ueno M, Nishizawa S, et al. Significance of increased oxygen extraction fraction in five-year prognosis of major cerebral arterial occlusive diseases. J Nucl Med 1999, 40: 1992–1998.
71. Hokari M, Kuroda S, Shiga T, Nakayama N, Tamaki N, Iwasaki Y. Impact of oxygen extraction fraction on long-term prognosis in patients with reduced blood flow and vasoreactivity because of occlusive carotid artery disease. Surg Neurol 2009, 71: 532–538; discussion 538, 538–539.
72. Baron JC, Yamauchi H, Fujioka M, Endres M. Selective neuronal loss in ischemic stroke and cerebrovascular disease. J Cereb Blood Flow Metab 2014, 34: 2–18.
73. Matsubara S, Moroi J, Suzuki A, Sasaki M, Nagata K, Kanno I, et al. Analysis of cerebral perfusion and metabolism assessed with positron emission tomography before and after carotid artery stenting. Clinical article. J Neurosurg 2009, 111: 28–36.
74. Kuhl DE, Phelps ME, Kowell AP, Metter EJ, Selin C, Winter J. Effects of stroke on local cerebral metabolism and perfusion: Mapping by emission computed tomography of 18FDG and 13NH3. Ann Neurol 1980, 8: 47–60.
75. Baron JC, Bousser MG, Comar D, Castaigne P. “Crossed cerebellar diaschisis” in human supratentorial brain infarction. Trans Am Neurol Assoc 1980, 105: 459–461.
76. Sobesky J, Thiel A, Ghaemi M, Hilker RH, Rudolf J, Jacobs AH, et al. Crossed cerebellar diaschisis in acute human stroke: a PET study of serial changes and response to supratentorial reperfusion. J Cereb Blood Flow Metab 2005, 25: 1685–1691.
77. Feeney DM, Baron JC. Diaschisis. Stroke 1986, 17: 817–830.
78. Szelies B, Herholz K, Pawlik G, Karbe H, Hebold I, Heiss WD. Widespread functional effects of discrete thalamic infarction. Arch Neurol 1991, 48: 178–182.
79. Madai VI, Altaner A, Stengl KL, Zaro-Weber O, Heiss WD, von Samson-Himmelstjerna FC, et al. Crossed cerebellar diaschisis after stroke: can perfusion-weighted MRI show functional inactivation? J Cereb Blood Flow Metab 2011, 31: 1493–1500.
80. Kushner M, Reivich M, Fieschi C, Silver F, Chawluk J, Rosen M, et al. Metabolic and clinical correlates of acute ischemic infarction. Neurology 1987, 37: 1103–1110.
81. Karbe H, Herholz K, Szelies B, Pawlik G, Wienhard K, Heiss WD. Regional metabolic correlates of Token test results in cortical and subcortical left hemispheric infarction. Neurology 1989, 39: 1083–1088.
82. Nudo RJ. Mechanisms for recovery of motor function following cortical damage. Curr Opin Neurobiol 2006, 16: 638–644.
83. Mountz JM. Nuclear medicine in the rehabilitative treatment evaluation in stroke recovery. Role of diaschisis resolution and cerebral reorganization. Eura Medicophys 2007, 43: 221–239.
84. Heiss W-D. WSO Leadership in Stroke Medicine Award Lecture Vienna, September 26, 2008: Functional imaging correlates to disturbance and recovery of language function. Int J Stroke 2009, 4: 129–136.
85. Cramer SC, Nudo RJ (Eds). Brain Repair after Stroke. Cambridge: Cambridge University Press, 2010.
86. Roman GC, Sachdev P, Royall DR, Bullock RA, Orgogozo JM, Lopez-Pousa S, et al. Vascular cognitive disorder: a new diagnostic category updating vascular cognitive impairment and vascular dementia. J Neurol Sci 2004, 226: 81–87.
87. Rockwood K, Wentzel C, Hachinski V, Hogan DB, MacKnight C, McDowell I. Prevalence and outcomes of vascular cognitive impairment. Vascular Cognitive Impairment Investigators of the Canadian Study of Health and Aging. Neurology 2000, 54: 447–451.
88. Ferrer I. Cognitive impairment of vascular origin: Neuropathology of cognitive impairment of vascular origin. J Neurol Sci 2010, 299(1–2): 139–149
89. Jellinger KA. The pathology of “vascular dementia”: a critical update. J Alzheimers Dis 2008, 14: 107–123.
90. Hachinski VC, Lassen NA, Marshall J. Multi-infarct dementia. A cause of mental deterioration in the elderly. Lancet 1974, 2: 207–210.
91. Moorhouse P, Rockwood K. Vascular cognitive impairment: current concepts and clinical developments. Lancet Neurol 2008, 7: 246–255.
92. Heiss WD, Zimmermann-Meinzingen S. PET imaging in the differential diagnosis of vascular dementia. J Neurol Sci 2012, 322: 268–273.
93. Frackowiak RSJ, Pozzilli C, Legg NJ, Du Boulay GH, Marshall J, Lenzi GL, et al. Regional cerebral oxygen supply and utilization in dementia. A clinical and physiological study with oxygen-15 and positron tomograhy. Brain 1981, 104: 753–778.
94. Meguro K, Hatazawa J, Yamaguchi T, Itoh M, Matsuzawa T, Ono S, et al. Cerebral circulation and oxygen metabolism associated with subclinical periventricular hyperintensity as shown by magnetic resonance imaging. Ann Neurol 1990, 28: 378–383.
95. Benson DF, Kuhl DE, Hawkins RA, Phelps ME, Cummings JL, Tsai SY. The fluorodeoxyglucose 18F scan in Alzheimer’s disease and multi-infarct dementia. Arch Neurol 1983, 40: 711–714.
96. Leys D, Henon H, Mackowiak-Cordoliani MA, Pasquier F. Poststroke dementia. Lancet Neurol 2005, 4: 752–759.
97. Cechetto DF, Hachinski V, Whitehead SN. Vascular risk factors and Alzheimer’s disease. Expert Rev Neurother 2008, 8: 743–750.
98. Whitehead SN, Cheng G, Hachinski VC, Cechetto DF. Progressive increase in infarct size, neuroinflammation, and cognitive deficits in the presence of high levels of amyloid. Stroke 2007, 38: 3245–3250.
99. Sokoloff L, Ingvar DH, Lassen NA. Influence of functional activity on local cerebral glucose utilization. Brain Work 1975: 385–388.
100. Heiss WD, Turnheim M, Vollmer R, Rappelsberger P. Coupling between neuronal activity and focal blood flow in experimental seizures. Electroenceph Clin Neurophysiol 1979, 47: 396–403.
101. Ingvar DH. Functional landscapes of the dominant hemisphere. Brain Res 1976, 107: 181–197.
102. Phelps ME, Mazziotta JC. Positron emission tomography: Human brain function and biochemistry. Science 1985, 228: 799–809.
103. Raichle ME. Behind the scenes of functional brain imaging: a historical and physiological perspective. Proc Natl Acad Sci U S A 1998, 95: 765–772.
104. Thiel A, Schumacher B, Wienhard K, Gairing S, Kracht LW, Wagner R, et al. Direct demonstration of transcallosal disinhibition in language networks. J Cereb Blood Flow Metab 2006, 26: 1122–1127.
105. Thiel A, Habedank B, Herholz K, Kessler J, Winhuisen L, Haupt WF, et al. From the left to the right: How the brain compensates progressive loss of language function. Brain Lang 2006, 98: 57–65.
106. Saur D, Lange R, Baumgaertner A, Schraknepper V, Willmes K, Rijntjes M, et al. Dynamics of language reorganization after stroke. Brain 2006, 129: 1371–1384.
107. Heiss WD, Kessler J, Thiel A, Ghaemi M, Karbe H. Differential capacity of left and right hemispheric areas for compensation of poststroke aphasia. Ann Neurol 1999, 45: 430–438.
108. Richter M, Miltner WH, Straube T. Association between therapy outcome and right-hemispheric activation in chronic aphasia. Brain 2008, 131: 1391–1401.
109. Thiel A, Hartmann A, Rubi-Fessen I, Anglade C, Kracht L, Weiduschat N, et al. Effects of noninvasive brain stimulation on language networks and recovery in early poststroke aphasia. Stroke 2013, 44: 2240–2246.
110. Thiel A, Schumacher B, Wienhard K, Gairing S, Kracht LW, Wagner R, et al. Direct demonstration of transcallosal disinhibition in language networks. J Cereb Blood Flow Metab 2006, 26: 1122–1127.
111. Wehrl HF, Judenhofer MS, Wiehr S, Pichler BJ. Pre-clinical PET/MR: technological advances and new perspectives in biomedical research. Eur J Nucl Med Mol Imaging 2009, 36Suppl 1: S56–68.
112. Heiss W-D. The potential of PET/MR for brain imaging. Eur J Nucl MEd Mol Imaging 2009, 36.Suppl 1: 105–112.
113. Sauter AW, Wehrl HF, Kolb A, Judenhofer MS, Pichler BJ. Combined PET/MRI: one step further in multimodality imaging. Trends Mol Med 2010, 16: 508–515.
114. Catana C, Drzezga A, Heiss WD, Rosen BR. PET/MRI for neurologic applications. J Nucl Med 2012, 53(12): 1916–1925.
115. Schlemmer HP, Pichler BJ, Schmand M, Burbar Z, Michel C, Ladebeck R, et al. Simultaneous MR/PET imaging of the human brain: Feasibility study. Radiology 2008, 248: 1028–1035.
116. Lanfermann H, Kugel H, Heindel W, Herholz K, Heiss WD, Lackner K. Metabolic changes in acute and subacute cerebral infarctions: findings at proton MR spectroscopic imaging. Radiology 1995, 196: 203–210.
117. Hsu AR, Chen X. Advances in anatomic, functional, and molecular imaging of angiogenesis. J Nucl Med 2008, 49: 511–514.
118. Hoehn M, Himmelreich U, Kruttwig K, Wiedermann D. Molecular and cellular MR imaging: potentials and challenges for neurological applications. J Magn Reson Imaging 2008, 27: 941–954.
119. Bliss T, Guzman R, Daadi M, Steinberg GK. Cell transplantation therapy for stroke. Stroke 2007, 38: 817–826.
120. Wang J, Chao F, Han F, Zhang G, Xi Q, Li J, et al. PET demonstrates functional recovery after transplantation of induced pluripotent stem cells in a rat model of cerebral ischemic injury. J Nucl Med 2013, 54: 785–792.
121. Heiss WD, Grond M, Thiel A, Ghaemi M, Sobesky J, Rudolf J, Bauer B, Wienhard K. Permanent cortical damage detected by flumazenil positron emission tomography in acute stroke. Stroke 1998, 29(2): 454–461.